Protalix BioTherapeutics Announces AIR DNase(TM) Data Presented at the 38th European Cystic Fibrosis Conference

By: via Benzinga
Protalix BioTherapeutics, Inc. (NYSE MKT: PLX) (TASE:PLX) announced today that pre-clinical data for AIR DNaseTM (PRX-110) for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.